Skip to main content
. 2011 Oct 13;7(10):e1002282. doi: 10.1371/journal.ppat.1002282

Table 1. Protein-coding variations unique to the vaccine strain PRV Bartha, in comparison to the virulent strains PRV Becker and Kaplan.

Gene a Amino acid residues found in PRV Bartha, which differ from PRV Becker & Kaplan b
ICP27 (UL54) G9D, T258A
UL52 A824V
dUTPase (UL50) S20G
gN (UL49.5) L7P
VP22 (UL49) T126A, 129(+A)
VP16 (UL48) Q171R, T386A
VP13/14 (UL47) V7A, E63D, E84G, 96–99(EEEE>Δ), Y144H, P432A
VP11/12 (UL46) W108R, 301–304(AAVV>Δ), 508–509(GE>Δ), A532T
gB (UL27) Y267H, R440Q, 506–507(SP>AA), P509Q
ICP18.5 (UL28) A517V
UL32 W266R, A289V
UL33 7(+G)
UL34 D188G, Y221C
VP26 (UL35) H65R
VP1/2 (UL36) c T811A, L2152P, 2180(+EPTPAAKLAPPAPPPAKPA * )2, L2182T, H2219P, P2314L, K2449R, V2465A, T2666A, 2686(+PGDDVVPA), V2853F, E2876G
RR1 (UL39) S95N, T294A
RR2 (UL40) G266D
vhs (UL41) M353V
UL42 E331A
gC (UL44) L14P, E43A, P156S
scaffold (UL26.5) 120(+Q)
VP24 (UL26) 365(+Q)
gH (UL22) V59D, P438S, 481–482(EE>G)
UL21 H37R, E355D, V375A
UL17 G239D, S341G, P521L
UL15 K404R
UL14 Q18R
V18.8 (UL13) A13V
AN (UL12) 178(+GD), V474A
UL11 Y49C
gM (UL10) 59–60(TS>AP)
OBP (UL9) D4P, 6–7(GG>RV)
UL8 A52V, V509I
UL6 4(+AA)
UL5 A2Δ
UL3.5 H94Q, R193H
UL3 T97Δ
UNG (UL2) A286S
ICP4 (IE180) Q92Δ, R195Δ, S234P, N296S, L319P, 371(P>LA), S752A, 854(+ESGSST), S954Δ, V1218A, H1390R
ICP22 (US1) V31L, 239(+DEDEEEEE), 254(+DEDGLCEDE)
gG (US4) 306–307(RG>HR)
gD (US6) V69A, N82S
gI (US7), gE (US8), US9, US2 Bartha deletion region
a

Proteins are listed in order of occurrence along the genome (see Figure 3 for full list and functions). Table 2 lists proteins with AA differences from PRV Kaplan that are shared by PRV Bartha and Becker strains.

b

Bold indicates AA differences discussed in the text. Single AA residues changes are written in standard format, including the Kaplan reference strain AA, its position, and the AA residue found in Bartha's protein sequence, e.g. S100P. Insertions in PRV Bartha are indicated by the AA position in Kaplan followed by “+” and the new AAs, e.g. 100(+RR). Deletions are indicated by the symbol Δ. Sequential changes are combined and shown with the Kaplan strain AA positions first, followed by the relevant Kaplan AA residues, then “>”, and finally the new alternative AA residues, e.g. 100–102(RAR>EDA).

c

Subscript on parentheses in UL36 indicates multiple copies of a repeating unit.

*Final alanine (A) in this repeat unit changes to valine (V) in the second copy of the repeat unit.